Education, Science, Technology, Innovation and Life
Open Access
Sign In
  1. Home
  2. Journals
  3. MEDS Public Health and Preventive Medicine
  4. Vol 4, Issue 1, 2024

A review of research progress on the comorbidity of sarcopenia and cardiovascular diseases in the elderly

Download as PDF

DOI: 10.23977/phpm.2024.040118 | Downloads: 8 | Views: 171

Author(s)

Qiuran Jia 1, Junfan Wu 2

Affiliation(s)

1 Beijing Haidian Hospital, Beijing, 100086, China
2 Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China

Corresponding Author

Junfan Wu

ABSTRACT

As the global population ages, age-related diseases, particularly cardiovascular ailments, pose formidable challenges to healthcare systems worldwide. This review highlights the importance of exercise in both the prevention and rehabilitation of cardiovascular disorders, underscoring the pronounced correlation between diminished exercise capacity in the elderly and heightened disease susceptibility. Moreover, sarcopenia, defined by reduced muscle mass and function, is intricately linked to cardiovascular health. The article reviews recent studies on the pathophysiology, interactions, mechanisms, clinical presentations, diagnostic criteria, and treatments of sarcopenia and cardiovascular diseases, with the objective of fostering a nuanced comprehension of these maladies.

KEYWORDS

Cardiovascular Diseases, Sarcopenia, Exercise, Pathophysiology

CITE THIS PAPER

Qiuran Jia, Junfan Wu, A review of research progress on the comorbidity of sarcopenia and cardiovascular diseases in the elderly. MEDS Public Health and Preventive Medicine (2024) Vol. 4: 122-128. DOI: http://dx.doi.org/10.23977/phpm.2024.040118.

REFERENCES

[1] Ken-ichiro Sasaki, Yoshihiro Fukumoto, "Sarcopenia as a comorbidity of cardiovascular disease," Journal of Cardiology 79 (2022) 596–604.
[2] Xinrong Zuo et al., "Sarcopenia and cardiovascular diseases: A systematic review and meta-analysis," Journal of Cachexia, Sarcopenia and Muscle 2023; 14: 1183–1198.
[3] Nana He et al., "Relationship between Sarcopenia and Cardiovascular Diseases in the Elderly: An Overview," Front. Cardiovasc. Med., 09 December 2021.
[4] Cruz-Jentoft AJ et al., "Sarcopenia: revised European consensus on definition and diagnosis," Age Ageing, 2019, 48(1): 16-31. DOI: 10.1093 /ageing /afy169.
[5] Chen L-K et al., "Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia," J Am Med Dir Assoc, 2014, 15(2): 95-101.
[6] Dhillon RJ, Hasni S. "Pathogenesis and management of sarcopenia," Clin Geriatr Med, 2017, 33( 1) : 17-26.
[7] Kotseva, K., et al., "Lifestyle and Impact on Cardiovascular Risk Factor Control in Coronary Patients Across 27 Countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V Registry." European Journal of Preventive Cardiology, 2019. 
[8] Libby, P., et al., "Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy." New England Journal of Medicine, 2019. 
[9] Heidenreich, P. A., et al., "Forecasting the Future of Cardiovascular Disease in the United States: A Policy Statement from the American Heart Association." Circulation, 2013. 
[10] Zhisheng Tan et al., "The relationship between muscular atrophy/sarcopenia and cardiovascular diseases in the elderly: a bibliometrics study," Ann Palliat Med 2021;10(8):9136-9148 | https://dx.doi.org/10.21037/apm-21-2144.
[11] Liu HW,Chen YJ,Chang YC,et al., “A low-molecular weight polyphenol derived from lychee,alleviates muscle loss in diabetes by suppressing atrogin-1 and MuRF1,”  Nutrients,2017,9( 9) : e1040. DOI: 10.3390 /nu9091040.
[12] Stewart RAH, Held C, Krug-Gourley S, et al., "Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients with Stable Coronary Heart Disease.," J Am Heart Assoc 2019;8: e010641.
[13] Yoon MS, "mTOR as a key regulator in maintaining skeletal muscle mass," Front Physiol, 2017, 8 ( 10) : 788. DOI: 10. 3389 /fphys.2017.00788.
[14] Gueugneau M, Coudy-Gandilhon C,Meunier B,et al., "Lower skeletal muscle capillarization in hypertensive elderly men," Exp Gerontol, 2016, 76(4) : 80-88.
[15] Lin YL, Chen SY, Lai YH, et al., "AngiotensinⅡreceptor blockade is associated with preserved muscle strength in chronic hemodialysis patients," BMC Nephrol, 2019, 20( 1) : 54.

Subscription
E-Mail Alert
Most popular papers
Call for Special Issue
Publication Ethics & OA Statement
Plagiarism Policy
Contact Us
Downloads: 2554
Visits: 102249

Sponsors, Associates, and Links

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.